46. Stereotactic Mammotome Breast Biopsy – analisis of results  by Murawa, P. et al.
at the end ot treatmenł. We have noted also 38
patients (15%) ot 254 patients, with deacresing
hemoglobin level during treatment higher than
1 gid!.
Results: No impact on outcome ot treatment
was observed in the group ot patients with low
level ot Hgb betore irradiation. Inrease ot
locoregional failure ot postoperative radiotherapy
was noted in group of patients with Hgb level at
the end of irradiation below 13 g/dl (p = 0,004)
and also in group ot patients with decreasing of
Hgb level during treatment (p = 0,038).
Conclusions: Low Hgb levels at the end of
postoperative irradiation and decreasing during
irradiation were associated with a statistically
signiticant an increase in locoregional failure ot
patients with advanced carcinoma of larynx.
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surrounding tissues, excellent cosmetic eftect
,economical procedure.
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The purpose ot work is to assess stereotactic
mammotome biopsy technology in diagnostics
ot nonpalpable breast lesions. In the period tram
April to December 2000 mammotome biopsy
procedure was performed on395 female patients
at the I Oncological Surgery department the
Greatpoland CancerCenter in Poznań .In all
patients, diagnosed lesions were non-palpable
and categorisedas BI-RADS III, IV, V. Patients
were aged between 16 and 78 (average 52.6
years). They divided into three groups
depending on radiological characteristics ot the
examined lesions - separate analyses were
carried out tor patients with microcalcifications
suspicious tumores and radial scar. Diagnostic
examination was performed on an ambulatory
basis. Procedurewas carried out on a Fischer
mammotome table using the Mammotome
Biopsy System. The Cancers were detected in
17 % cases .AII patients with diagnosed cancer
underwent further surgical procedure. In 83 %
patients in whom begin lesions were tound
mammography screening was recommended at
6 month intervals. The Stereotactic
Mammotome Breast Biopsy System is a
sensitive, minimally invasive diagnostic
technology characterised by: very high
diagnostic precision, minimai traumatisation of
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Patients and mełhods: From 1993 to 2001
thirty two children underwent bone marraw
transplantation (BMT) tor ALL (12 in I CR and 20
in II CR after early BM or BM/organ relapse).
Except 2 syngeneic all other were HLA-identical
siblings transplants. Ali patients (pts) were
conditioned with FTBI 2 x 1,5 Gy for 4 days
(total dose 12 Gy) with lung shielding (9 Gy) and
CY 60 mg/kg i. v for 2 days (total dose 120
mg/kg) (n=1 in I CR and n = 11 in II CR) or VP
60 mg/kg i. v (n = 11 in I CR and n = 9 in II CR).
Pts in I CR have been given 1,1-4,9x1 OB
MNC/kg (med. 2,7x10B/kg), while pts in II CR
1,9-4,Ox1 OB MNC/kg (med. 2,7x1 OB/kg). For
GvHD prevention CsA 3 mg/kg/d i.v was
administered alone in 22 pts (n = 9 in I CR and n
= 13 in II CR) or in combination with "short" MTX
+/- PRED in 8 pts (n =3 in I CR and n =5 in II
CR). Two pts transplanted with syngeneic BM
received no GvHD prevention. Regimen related
toxicity (RRT) was graded according to the
system developed by Bearman et al. (1988).
Results: Only mild or moderate expression ot
RRT was observed (Gl toxicity 10 - 80%, 110 -
4%; stomatitis 10 - 40%, 110 - 20%; hepatic
toxicity 10 - 28%; renal, bladder and cardiac
toxicity 10 - 4%) and no transplant related deaths
occured (TRM = 0%). Among 12 pts
transplanted in I CR only one child relapsed 4
months trom BMT, while remaining 11 pts are
alive in CCR with a median follow-up of
33months (range 6 to 66 months) and 92%
prabability of 5-year EFS. Of 20 children
transplanted in II CR 6 relapsed 1-14 months
tram BMT (median 6,5 months). Fourteen ot
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